2-乙酰氧基-4-叔丁基苯基乙酸酯 | 80869-94-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚酯
• 中文名称: 2-乙酰氧基-4-叔丁基苯基乙酸酯
• 英文名称: 1,2-diacetoxy-4-tert-butyl-benzene
• 英文别名: 1,2-Diacetoxy-4-tert-butyl-benzol；3,4-Diacetoxy-1-tert.-butyl-benzol；(2-Acetyloxy-4-tert-butylphenyl) acetate
• CAS: 80869-94-9
• 化学式: C₁₄H₁₈O₄
• 分子量: 250.295
• InChiKey: NBDHUKNVZPIOEW-UHFFFAOYSA-N

物化性质

• 保留指数：
  1663.5

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  6,6-diacetoxy-4-tert-butyl-cyclohexa-2,4-dienone 在 吡啶 、 乙醇 、 钯 作用下， 生成 2-乙酰氧基-4-叔丁基苯基乙酸酯
  参考文献：
  名称：

  �ber die Einwirkung von Bleitetraacetat auf Phenole III

  摘要：

  DOI：

  10.1007/bf00899629

文献信息

• Efficient <i>ortho</i>-Oxidation of Phenols with Diacyl Peroxides
  作者：Masahiro Tada、Risa Ishiguro、Ryohei Izumi

  DOI：10.1248/cpb.56.239

  日期：——

  A stable symmetric diacyl peroxide, m-chlorobenzoyl peroxide (mCBPO), and an asymmetric diacyl peroxide, chloroacetyl m-chlorobenzoyl peroxide (CAMCBPO), were synthesized from m-chloroperbenzoic acid. Both peroxides oxidized phenols selectively at the ortho position predoninantly. CAMCBPO gave para-oxidized compounds as minor products from some phenols. The improvement of the yield of ortho-oxidation of phenols with mCBPO was also reported.

  从间氯过苯甲酸出发，合成了稳定的对称二酰基过氧化物间氯苯甲酰过氧化物（mCBPO）和非对称二酰基过氧化物氯乙酰基间氯苯甲酰过氧化物（CAMCBPO）。这两种过氧化物主要选择性地在苯酚的邻位进行氧化。从某些苯酚出发，CAMCBPO得到了少量对位氧化产物。还报道了使用mCBPO提高苯酚邻位氧化产率的方法。
• Fluoroboric acid adsorbed on silica gel as a new and efficient catalyst for acylation of phenols, thiols, alcohols, and amines
  作者：Asit K. Chakraborti、Rajesh Gulhane

  DOI：10.1016/s0040-4039(03)00683-x

  日期：2003.4

  Fluoroboric acid supported on silica gel efficiently catalyzes acylation of structurally diverse phenols, alcohols, thiols, and amines under solvent free conditions. Acid-sensitive alcohols are smoothly acylated without competitive side reactions.

  负载在硅胶上的氟硼酸可在无溶剂条件下有效催化结构多样的酚，醇，硫醇和胺的酰化反应。对酸敏感的醇被平滑酰化而没有竞争性副反应。
• Indium(III) chloride as a new, highly efficient, and versatile catalyst for acylation of phenols, thiols, alcohols, and amines
  作者：Asit K. Chakraborti、Rajesh Gulhane

  DOI：10.1016/s0040-4039(03)01641-1

  日期：2003.8

  Indium(III) chloride efficiently catalyses the acylation of structurally diverse phenols, alcohols, thiols, and amines under solvent free conditions. Acid sensitive alcohols are smoothly acylated without competitive side reactions. Acylation of 2-hydroxynaphthalene is carried out with carboxylic acids adopting the mixed anhydride protocol using trifluoroacetic anhydride.

  氯化铟（III）在无溶剂条件下有效催化结构多样的酚，醇，硫醇和胺的酰化。对酸敏感的醇被平滑酰化而没有竞争性副反应。通过使用三氟乙酸酐的混合酸酐方案，将羧酸与2-羟基萘酰化。
• CATALYST PROCESS MODIFICATION AND POLYMERIZATION THEREOF
  申请人：INDIAN OIL CORPORATION LTD.

  公开号：US20160215077A1

  公开（公告）日：2016-07-28

  The present invention describes a process for preparation of catalyst component comprising contacting magnesium based precursor along with an internal donor based on phenylene dioates with an acyl halides in a solvent to obtain a solid precatalyst component; and contacting the solid precatalyst component with transition metal compound to obtain the catalyst component. The present invention also relates to a process for preparation of a catalyst system from said catalyst component and preparation of a polyolefins having free flowing characteristics with bulk densities (BD) of at least about 0.3 g/cc from the catalyst system.

  本发明描述了一种制备催化剂组分的方法，包括将基于镁的前体物与基于苯二酸酯的内部供体接触，并在溶剂中与酰卤反应，以获得固体前催化剂组分；并将固体前催化剂组分与过渡金属化合物接触，以获得催化剂组分。本发明还涉及从该催化剂组分制备催化剂体系的方法，以及使用该催化剂体系制备具有自由流动特性且体积密度（BD）至少约为0.3 g/cc的聚烯烃的方法。
• Combination therapies for treating cancer
  申请人：RedHill Biopharma Ltd.

  公开号：US10463654B2

  公开（公告）日：2019-11-05

  Provided are methods for treating cancer in a patient by administering at least one antibiotic selected from the group consisting of clofazimine, rifabutin and clarithromycin, in combination with an aryladamantane compound. In an embodiment, the aryladamantane compound is [3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide], or a pharmaceutically acceptable salt thereof.

  本发明提供了通过施用至少一种选自氯法齐明、利福布汀和克拉霉素组成的组的抗生素与芳基金刚烷化合物联合治疗患者癌症的方法。在一个实施方案中，芳基金刚烷化合物是[3-(4-氯苯基)-金刚烷-1-羧酸(吡啶-4-基甲基)酰胺]或其药学上可接受的盐。

表征谱图